Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH) - Archive ouverte HAL Access content directly
Journal Articles Hepatology Year : 2020

Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH)

(1) , (1) , (1) , (1) , (2, 3) , (2, 3) , (4) , (5) , (3, 2) , (1) , (1) , (1)
1
2
3
4
5

Abstract

Non-Alcoholic SteatoHepatitis (NASH) is considered as a pivotal stage in Non-Alcoholic Fatty Liver Disease (NAFLD) progression, as it paves the way for severe liver injuries such as fibrosis and cirrhosis. The etiology of human NASH is multi-factorial and identifying reliable molecular players and/or biomarkers has proven difficult. Together with the inappropriate consideration of risk factors revealed by epidemiological studies (altered glucose homeostasis, obesity, ethnicity, sex…), the limited availability of representative NASH cohorts with associated liver biopsies, the gold standard for NASH diagnosis, probably explains the poor overlap between published "omics"-defined NASH signatures.
Fichier principal
Vignette du fichier
Vandel_et_al_main_text_version auteurs HAL.pdf (2.28 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-02617094 , version 1 (25-05-2020)

Identifiers

Cite

Jimmy Vandel, Julie Dubois-Chevalier, Celine Gheeraert, Bruno Derudas, Violetta Raverdy, et al.. Hepatic molecular signatures highlight the sexual dimorphism of Non-Alcoholic SteatoHepatitis (NASH). Hepatology, 2020, ⟨10.1002/HEP.31312⟩. ⟨inserm-02617094⟩
94 View
58 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More